CX Institutional
RPRX icon

CX Institutional’s Royalty Pharma RPRX Stock Holding History

CX Institutional’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20K Buy
347
+1
+0.3% +$59 ﹤0.01% 1233
2026
Q2 		$19K Buy
346
+1
+0.3% +$52 ﹤0.01% 1187
2026
Q1 		$17K Buy
345
+293
+563% +$12.8K ﹤0.01% 1166
2025
Q4 		$2K Hold
52
– – ﹤0.01% 1394
2025
Q3 		$2K Hold
52
– – ﹤0.01% 1316
2025
Q2 		$2K Hold
52
– – ﹤0.01% 1158
2025
Q1 		$2K Buy
+52
New +$1.65K ﹤0.01% 1148

Other funds holding RPRX

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Hosking Partners
Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return
Kepler Cheuvreux
Kepler Cheuvreux Nyon $1.65B AUM 36.86% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Kirr Marbach & Co
Kirr Marbach & Co Columbus, Indiana $530M AUM 14.37% 1-Year Est. Return
Triasima Portfolio Management
Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

CX Institutional's RPRX Position: Q3 2026 in Review

CX Institutional increased its Royalty Pharma (RPRX) stake by 0.29% in Q3 2026, buying an estimated $59 and bringing the position to 347 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

CX Institutional first reported a position in RPRX in Q1 2025 and has held it in 7 quarters since. 129 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • CX Institutional held 347 shares of Royalty Pharma worth $20K as of Q3 2026.
  • CX Institutional bought 1 Royalty Pharma share in Q3 2026, an estimated $59.
  • Royalty Pharma made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #1233 holding.
  • CX Institutional first reported a position in Royalty Pharma in Q1 2025 and has held it in 7 quarters since.
  • 129 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.